Tune Therapeutics is orchestrating the power of the epigenome to treat complex, pervasive diseases that have long eluded treatment.

Sectors
Healthcare
Life Sciences
First Invested
2020
Early
Company Status
Private
Board Members
Ali Behbahani, MD